financetom
Business
financetom
/
Business
/
What's Going On With The Jump In Opendoor Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With The Jump In Opendoor Stock Today?
Nov 11, 2025 1:26 PM

Opendoor Technologies Inc ( OPEN ) shares are trading higher on Tuesday. CEO Kaz Nejatian announced he would purchase $1 million worth of company shares.

OPEN is showing upward movement. See what is happening here.

What To Know: Just two months after taking over as leader, Nejatian declared on X Monday night that he and his family would buy the shares when the market opened on Tuesday morning, the first day that regulations allowed him to do so.

“I will talk about Opendoor’s product frequently and its stock rarely. That’s because my job is to build the product and the company, and that will have good secondary outcomes,” the CEO said in the post. “Tomorrow is the first day I am allowed to buy OPEN and my family is buying $1M at the open.”

The CEO made the pledge a few days after Opendoor ( OPEN ) published third-quarter results. The company continues to face problems as fewer homes are being purchased and sold, which has made some investors doubt the viability of its iBuying-focused business model in the long-run.

Nejatian’s stock purchase seems to be an attempt to combat market turbulence and strengthen his faith in Opendoor’s prospects for growth.

According to , according to JPMorgan analyst Dae Lee, a major transformation is underway as the new management “refounds the company” and shifts to a volume-driven strategy intended to accelerate acquisitions and clear legacy inventory. According to Lee, the home-flipping platform’s reset may finally lead it toward long-term profitability, and he keeps his Overweight rating and $8 price target for December 2026.

The impact of a “risk-averse approach” from previous leadership has impacted the company’s third-quarter results, but Lee views that cleanup phase as essential preparation. In the fourth-quarter, Opendoor ( OPEN ) anticipates acquisitions to rise by at least 35% on a quarterly basis as a result of lower spreads and recalculated pricing models.

OPEN Analyst Ratings

Analyst sentiment around Opendoor ( OPEN ) has leaned bearish lately, with several downgrades and underperform ratings. On November 10, Keefe, Bruyette & Woods kept their underperform rating but raised their price target from $1.00 to $2.00, following an earlier downgrade in August.

Zelman & Associates also cut their rating to underperform from neutral in early August, setting a $1.00 target. Around the same time, Citigroup downgraded the stock to sell with a more pessimistic $0.70 target. UBS took a more balanced view, holding its neutral rating while nudging the target up from $1.30 to $1.60.

OPEN Price Action: Opendoor ( OPEN ) shares were up 6.9% at $8.51 at the time of publication on Tuesday, according to Benzinga Pro.

Read Next:

Opendoor Stock Falls After Mixed Q3 Results

Image: Tada Images/Shutterstock.com

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
Nov 14, 2025
01:02 PM EST, 11/14/2025 (MT Newswires) -- Consumer stocks were mixed Friday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) easing 0.3% and the Consumer Discretionary Select Sector SPDR Fund (XLY) fractionally higher. In corporate news, Walmart ( WMT ) said Friday that Doug McMillon will retire as chief executive of the retail giant at the end of...
Cartesian Pauses Lupus And Multiple Myeloma Studies As It Shifts Development Focus
Cartesian Pauses Lupus And Multiple Myeloma Studies As It Shifts Development Focus
Nov 14, 2025
Cartesian Therapeutics, Inc. ( RNAC ) on Friday shared initial data from the ongoing Phase 2 open-label trial of Descartes-08, its lead cell therapy candidate, for systemic lupus erythematosus (SLE). SLE is a chronic autoimmune disease where the body’s immune system attacks healthy tissues and organs, causing inflammation in various parts of the body, including joints, skin, kidneys, and the...
Gourmet supplier Innovative Food's Q3 revenue rises, driven by acquisitions
Gourmet supplier Innovative Food's Q3 revenue rises, driven by acquisitions
Nov 14, 2025
Overview * Innovative Food Holdings ( IVFH ) Q3 revenue grows 3.5% yr/yr, driven by acquisitions * GAAP net income from continuing operations declines compared to Q3 2024 Outlook * Company did not provide specific financial guidance for future periods in press release Result Drivers * ACQUISITIONS DRIVE REVENUE - Revenue growth in Q3 was primarily driven by contributions from...
Market Chatter: Ecopetrol Avoids Asset Freeze Amid $3 Billion Tax Dispute
Market Chatter: Ecopetrol Avoids Asset Freeze Amid $3 Billion Tax Dispute
Nov 14, 2025
01:01 PM EST, 11/14/2025 (MT Newswires) -- Ecopetrol ( EC ) will not have its assets frozen by Colombia's tax agency amid the ongoing $3 billion value-added tax or VAT dispute, Bloomberg reported Friday. The company's finance chief Camilo Barco told investors that the tax agency has stated that it discards any asset freeze, according to the report. Ecopetrol (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved